Profile
Robert Sebbag currently works at Action Against Hunger, as Director, PHAXIAM Therapeutics SA, as Independent Director from 2023, and Fondation Mérieux, as Founding Member.
Mr. Sebbag also formerly worked at Leem, as Director, Sanofi, as Vice President from 2006 to 2016, and Pherecydes Pharma SA, as Member-Supervisory Board.
Robert Sebbag active positions
| Companies | Position | Start |
|---|---|---|
| PHAXIAM THERAPEUTICS S.A. | Director/Board Member | 23/06/2023 |
Action Against Hunger
Action Against Hunger Services to the Health IndustryHealth Services Operates as a international humanitarian organization that aims and works to end world hunger | Director/Board Member | - |
Fondation Mérieux
Fondation Mérieux Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Corporate Officer/Principal | - |
Former positions of Robert Sebbag
| Companies | Position | End |
|---|---|---|
| SANOFI | Corporate Officer/Principal | 01/01/2016 |
Leem | Director/Board Member | - |
| PHERECYDES PHARMA | Director/Board Member | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Leem | |
Fondation Mérieux
Fondation Mérieux Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Action Against Hunger
Action Against Hunger Services to the Health IndustryHealth Services Operates as a international humanitarian organization that aims and works to end world hunger | Health Services |
Pherecydes Pharma SA
Pherecydes Pharma SA Pharmaceuticals: MajorHealth Technology Specializes in nano technologies for pharmaceutical purposes | Health Technology |
PHAXIAM Therapeutics SA
PHAXIAM Therapeutics SA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops red blood cell-based therapeutics for severe forms of cancer & orphan diseases | Health Technology |
- Stock Market
- Insiders
- Robert Sebbag
















